Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Steen

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Journal of the American Heart Association|April 27, 2022
Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United StatesDylan L Steen, Irfan Khan, Katherine Andrade, et al.
Clinical Therapeutics|August 22, 2018
Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General PracticeJean Ferrières, Katherine Gorcyca, Şerban R Iorga, et al.
Journal of Cell Science|April 17, 2003
AKAP149 is a novel PP1 specifier required to maintain nuclear envelope integrity in G1 phaseRikke L Steen, Monique Beullens, Helga B Landsverk, et al.
Clinical Genetics|November 1, 1988
Homozygosity for the transthyretin-met30-gene in two Swedish sibs with familial amyloidotic polyneuropathyG Holmgren, E Haettner, I Nordenson, et al.
Digestive Diseases and Sciences|October 1, 1996
Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathyO Suhr, A Danielsson, A Rydh, et al.
BMJ Open|February 19, 2017
Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelinesDylan L Steen, Irfan Khan, David Ansell, et al.
Clinical Cardiology|December 29, 2017
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22Dylan L Steen, Amarachi A Umez-Eronini, Jianping Guo, et al.
Transplantation Proceedings|April 1, 1996
Identification of Forssman as a major guinea pig xenoantigenT Cairns, M Gustavsson, L Goldberg, et al.
The International Journal of Biochemistry|January 1, 1987
Characterization of dolichol kinase from bovine thyroid microsomesL Steen, G Van Dessel, M De Wolf, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 5, 2013
Maternal outcomes in women supplemented with a high-protein drink in labourManuel C Vallejo, Benjamin T Cobb, Talora L Steen, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Journal of the American Heart Association|April 27, 2022
Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United StatesDylan L Steen, Irfan Khan, Katherine Andrade, et al.
Clinical Therapeutics|August 22, 2018
Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General PracticeJean Ferrières, Katherine Gorcyca, Şerban R Iorga, et al.
Journal of Cell Science|April 17, 2003
AKAP149 is a novel PP1 specifier required to maintain nuclear envelope integrity in G1 phaseRikke L Steen, Monique Beullens, Helga B Landsverk, et al.
Clinical Genetics|November 1, 1988
Homozygosity for the transthyretin-met30-gene in two Swedish sibs with familial amyloidotic polyneuropathyG Holmgren, E Haettner, I Nordenson, et al.
Digestive Diseases and Sciences|October 1, 1996
Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathyO Suhr, A Danielsson, A Rydh, et al.
BMJ Open|February 19, 2017
Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelinesDylan L Steen, Irfan Khan, David Ansell, et al.
Clinical Cardiology|December 29, 2017
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22Dylan L Steen, Amarachi A Umez-Eronini, Jianping Guo, et al.
Transplantation Proceedings|April 1, 1996
Identification of Forssman as a major guinea pig xenoantigenT Cairns, M Gustavsson, L Goldberg, et al.
The International Journal of Biochemistry|January 1, 1987
Characterization of dolichol kinase from bovine thyroid microsomesL Steen, G Van Dessel, M De Wolf, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 5, 2013
Maternal outcomes in women supplemented with a high-protein drink in labourManuel C Vallejo, Benjamin T Cobb, Talora L Steen, et al.
Pageof 11